The scale measures what does not count

Why muscle mass is one of the most underrated biomarkers for a long life. And what Health Professionals should do with it.

We all talk about weight. About BMI too. About muscle mass, rarely. Yet it says more about longevity than the number on the scale. Two studies show how much more.

What a 2014 UCLA study set straight

Preethi Srikanthan and Arun Karlamangla analyzed data from NHANES III. 3,659 adults, aged 55 and older, observed over 16 years. They calculated a Muscle Mass Index, skeletal muscle mass divided by height squared, and split participants into four quartiles.

The result, after the researchers adjusted for abdominal fat, cholesterol, blood pressure, diabetes, inflammation markers, and smoking. Those in the highest quartile of relative muscle mass had about 20 percent lower all-cause mortality than those in the lowest quartile (adjusted Hazard Ratio 0.80, 95 percent CI 0.66 to 0.97). Independent of all common risk factors.

Notable. Between the two upper quartiles, the effect flattened significantly. More muscle is good. Even more muscle does not necessarily save more lives. There is a threshold.

What 49 studies and 878,349 people confirm

A meta-analysis by Zhou and colleagues from 2023 broadened the picture enormously. 49 prospective studies, 878,349 participants, observation periods between 2.5 and 32 years, 61,055 documented deaths.

The pattern is consistent. People with low muscle mass had.

  • +36 percent all-cause mortality (RR 1.36, 95 percent CI 1.28 to 1.44)
  • +29 percent cardiovascular mortality
  • +14 percent cancer mortality
  • +36 percent respiratory mortality

One million people, three decades of observation, the same signal.

Why does muscle protect at all?

Three plausible mechanisms that do not exclude each other.

Muscle is reserve. In acute illness, after surgery, or under oncological therapy, the body draws on muscle protein. Those without reserve have no buffer.

Muscle is a fitness correlate. More muscle mass usually goes hand in hand with better cardiorespiratory performance. That is one of the most robust predictors of life expectancy.

Muscle is biography. Anyone with upper-quartile muscle mass at 65 has worked on it for decades. Movement, protein, sleep. Muscle is not just an outcome, it is the accumulated trace of a lifestyle.

On top of that, muscle is an endocrine-active organ. Myokines, glucose sink, insulin sensitivity. Pathways that keep working even when no training is happening.

What this means in practice

For clients. Two to three strength sessions per week are enough to turn the trend. Bodyweight, bands, or dumbbells. The entry point is secondary. Progressive overload is what matters. Weight, repetitions, or volume increased gradually. Not intensity. Consistency.

For Health Professionals. Muscle mass is a measurable quantity. DXA, BIA, grip strength, mid-arm circumference. Each method has its strengths. The more important question is not which one, but whether at all systematically.

Sarcopenia starts as early as age 30. Per decade we lose 3 to 8 percent of muscle mass. Those who recognize it early and counteract gain years. Those who wait until the scale sounds the alarm have already lost valuable time.

What we are getting at with SLOW

Muscle mass is a telling example of what drives us. A marker that has been documented for over a decade as prognostically highly relevant, and yet is still rarely captured systematically in daily care. Where noise fails, trust wins.

We build the platform that translates exactly this kind of data point, muscle mass and the full biomarker and genetic spectrum, into continuous, scientifically validated guidance. Practitioner-led, AI-supported, outcome-oriented. From data to results.

The scale shows weight. SLOW shows health. Measurable. Documented. Sustainable.

Which method do you use to capture muscle mass in your practice, and at what threshold do you take action? Drop it in the comments.

Sources.

  • Srikanthan P, Karlamangla AS. Muscle mass index as a predictor of longevity in older adults. Am J Med. 2014. 127(6). 547 to 553.
  • Zhou H-H, Liao Y, Peng Z, et al. Association of muscle wasting with mortality risk among adults. A systematic review and meta-analysis of prospective studies. J Cachexia Sarcopenia Muscle. 2023. 14(4). 1596 to 1612.